DK0914440T3 - Nukleinsyrevaccination mod parvovirusinfektioner - Google Patents

Nukleinsyrevaccination mod parvovirusinfektioner

Info

Publication number
DK0914440T3
DK0914440T3 DK97920711T DK97920711T DK0914440T3 DK 0914440 T3 DK0914440 T3 DK 0914440T3 DK 97920711 T DK97920711 T DK 97920711T DK 97920711 T DK97920711 T DK 97920711T DK 0914440 T3 DK0914440 T3 DK 0914440T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
vaccination against
acid vaccination
parvovirus infections
against parvovirus
Prior art date
Application number
DK97920711T
Other languages
Danish (da)
English (en)
Inventor
Metin Colpan
Joachim Schorr
Henry J Baker
Bruce F Smith
Original Assignee
Merial Ltd
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd, Univ Auburn filed Critical Merial Ltd
Application granted granted Critical
Publication of DK0914440T3 publication Critical patent/DK0914440T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK97920711T 1996-04-19 1997-04-18 Nukleinsyrevaccination mod parvovirusinfektioner DK0914440T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96106217 1996-04-19
PCT/EP1997/001943 WO1997040163A1 (en) 1996-04-19 1997-04-18 Nucleic acid vaccination for parvoviral infections

Publications (1)

Publication Number Publication Date
DK0914440T3 true DK0914440T3 (da) 2007-05-21

Family

ID=8222693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920711T DK0914440T3 (da) 1996-04-19 1997-04-18 Nukleinsyrevaccination mod parvovirusinfektioner

Country Status (10)

Country Link
US (1) US6465438B1 (https=)
EP (1) EP0914440B1 (https=)
JP (1) JP4117027B2 (https=)
AU (1) AU726059B2 (https=)
CA (1) CA2252375C (https=)
DE (1) DE69737231T2 (https=)
DK (1) DK0914440T3 (https=)
ES (1) ES2283015T3 (https=)
PT (1) PT914440E (https=)
WO (1) WO1997040163A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
US7294338B2 (en) 1996-07-19 2007-11-13 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
CA2223029A1 (en) * 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
EP0863151A1 (en) * 1997-02-12 1998-09-09 Akzo Nobel N.V. "Canine parvovirus dna vaccines"
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU753688B2 (en) * 1997-03-10 2002-10-24 Ottawa Civic Loeb Research Institute Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
ATE376062T1 (de) 1997-08-04 2007-11-15 Cell Genesys Inc Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
WO1999019471A1 (en) 1997-10-16 1999-04-22 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
NZ504894A (en) * 1997-12-02 2002-12-20 Powderject Vaccines Inc Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
ATE305507T1 (de) * 1998-05-14 2005-10-15 Coley Pharm Gmbh Verfahren zur regulierung der hematopoiese mit hilfe von cpg oligonukleotide
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
AU3593200A (en) 1999-02-09 2000-08-29 Powderject Vaccines, Inc. (mycobacterium tuberculosis), immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
CA2868618C (en) * 2002-10-16 2017-05-23 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
JP4850512B2 (ja) * 2003-05-15 2012-01-11 独立行政法人科学技術振興機構 免疫刺激剤
JP4817599B2 (ja) * 2003-12-25 2011-11-16 独立行政法人科学技術振興機構 免疫活性増強剤とこれを用いた免疫活性の増強方法
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
ATE479439T1 (de) * 2007-12-28 2010-09-15 Deutsches Krebsforsch Parvovirus mit cpg-angereichertem genom zur krebstherapie
WO2013163606A1 (en) 2012-04-27 2013-10-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vascular endothelial growth factor antagonists and methods for their use
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026827A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
DE69415462T2 (de) * 1993-01-23 1999-07-15 Inmunologia Y Genetica Aplicada, S.A., Madrid Synthetischen peptiden und impfstoffe gegen parvovirus
US6204059B1 (en) * 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer

Also Published As

Publication number Publication date
US6465438B1 (en) 2002-10-15
CA2252375C (en) 2011-12-20
JP2000509976A (ja) 2000-08-08
AU726059B2 (en) 2000-10-26
PT914440E (pt) 2007-02-28
DE69737231T2 (de) 2007-10-11
AU2699497A (en) 1997-11-12
JP4117027B2 (ja) 2008-07-09
ES2283015T3 (es) 2007-10-16
DE69737231D1 (de) 2007-02-22
EP0914440B1 (en) 2007-01-10
EP0914440A1 (en) 1999-05-12
WO1997040163A1 (en) 1997-10-30
CA2252375A1 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
DK0914440T3 (da) Nukleinsyrevaccination mod parvovirusinfektioner
EE200200158A (et) Immunostimulatoorsed nukleiinhapped
NO20003302L (no) Vaksine
DE69822943D1 (de) Mehrkammer-Sterilisationssystem
DE19982814T1 (de) Fahrtunterstützungssystem
BR9711853A (pt) Vacinas
FI972034A7 (fi) Polynukleotidi tuberkuloosirokote
DE69718600D1 (de) Polyether-Nukleinsäuren
NO20023597L (no) Universelt fastholdingssystem
NO20004758L (no) Vaksinesammensetning
EP1083926A4 (en) VACCINE
FI964423L (fi) DNA-sekvenssit
ID17860A (id) Komposisi vaksin
DE69934583D1 (de) Nukleinsäure-impfstoffe zur verhinderung der flaviviren-infektion
DE59710104D1 (de) Ansteuereinrichtung
EP0939130A4 (en) RNA POLYMERASE
NO20005599D0 (no) Vaksine
DE60026918D1 (de) Plattenlaufwerksystem
BR9506475A (pt) Sistema de acionamento
DK0975774T3 (da) Bakterielle plasmider
DE59809348D1 (de) Algizide mittel
DE69522429D1 (de) Flacher bürstenloser Motor
ATE212975T1 (de) Carbamoylcarbonsäureamidoxime
IT237539Y1 (it) Motospazzatrice perfezionata
ITMI951837A0 (it) Impianto per caseifici